In systemic sclerosis (SSc) (54), it was associated with the IFN score of SSc patients; in primary Sjogren’s syndrome (pSS), it was found to correlate with pSS disease activity levels (55); and in SLE, it was observed with substantially higher expression in SLE patients compared with HC (56). This evidence concerns the gene IFNA1 and Sjogren syndrome.